BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31579995)

  • 1. SERUM cardiac-specific biomarkers and atrial fibrillation in myotonic dystrophy type I.
    Russo V; Rago A; Atripaldi L; Leonardi S; Papa AA; Politano L; Golino P; Potpara TS; Nigro G
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2914-2919. PubMed ID: 31579995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interatrial block to predict atrial fibrillation in myotonic dystrophy type 1.
    Russo V; Papa AA; Rago A; Ciardiello C; Marano M; Proietti R; Politano L; Nigro G
    Neuromuscul Disord; 2018 Apr; 28(4):327-333. PubMed ID: 29567351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.
    Xiao J; Persson AP; Engström G; Johnson LSB
    BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
    Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
    Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of defibrillation shock in patients implanted with a subcutaneous defibrillator: a biomarker study.
    D'Onofrio A; Russo V; Bianchi V; Cavallaro C; Leonardi S; De Vivo S; Vecchione F; Rago A; Ammendola E; Tavoletta V; Atripaldi L; Mocavero PE; Nigro G
    Europace; 2018 Sep; 20(FI2):f233-f239. PubMed ID: 29095967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
    Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
    J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.
    Svennberg E; Henriksson P; Engdahl J; Hijazi Z; Al-Khalili F; Friberg L; Frykman V
    Heart; 2017 Aug; 103(16):1271-1277. PubMed ID: 28255099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.
    Staszewsky L; Meessen JMTA; Novelli D; Wienhues-Thelen UH; Disertori M; Maggioni AP; Masson S; Tognoni G; Franzosi MG; Lucci D; Latini R
    BMC Cardiovasc Disord; 2021 Nov; 21(1):553. PubMed ID: 34798808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study.
    Kumarathurai P; Mouridsen MR; Mattsson N; Larsen BS; Nielsen OW; Gerds TA; Sajadieh A
    Europace; 2017 Mar; 19(3):364-370. PubMed ID: 27194537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study.
    Almuwaqqat Z; O'Neal WT; Norby FL; Lutsey PL; Selvin E; Soliman EZ; Chen LY; Alonso A
    J Am Heart Assoc; 2019 Oct; 8(19):e013294. PubMed ID: 31564186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of N-terminal pro-brain natriuretic peptide as a predictor of atrial fibrillation after cardiac surgery.
    Kallel S; Jarrya A; Triki Z; Abdenadher M; Frikha J; Karoui A
    J Cardiovasc Surg (Torino); 2013 Jun; 54(3):403-11. PubMed ID: 23172377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
    Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT-ProBNP predicts rhythm stability after cardioversion of lone atrial fibrillation.
    Möllmann H; Weber M; Elsässer A; Nef H; Dill T; Rixe J; Schmitt J; Sperzel J; Hamm CW
    Circ J; 2008 Jun; 72(6):921-5. PubMed ID: 18503217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of N-terminal pro B-type natriuretic peptide (NT-proBNP) change with the risk of atrial fibrillation in the ARIC cohort.
    Li L; Selvin E; Lutsey PL; Hoogeveen RC; O'Neal WT; Soliman EZ; Chen LY; Alonso A
    Am Heart J; 2018 Oct; 204():119-127. PubMed ID: 30099337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-B-type natriuretic peptide as a marker of blunt cardiac contusion in trauma.
    Dogan H; Sarikaya S; Neijmann ST; Uysal E; Yucel N; Ozucelik DN; Okuturlar Y; Solak S; Sever N; Ayan C
    Int J Clin Exp Pathol; 2015; 8(6):6786-92. PubMed ID: 26261563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
    Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV
    Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation.
    Ma XX; Zhang YL; Hu B; Jiang WJ; Wang M; Zheng DY; Zhu MR; Xue XP
    J Interv Card Electrophysiol; 2017 Apr; 48(3):343-350. PubMed ID: 27943042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.